[1]
N. Kumari, R. C. Dwivedi, K. K. Singh, S. K. Yadav, D. Kumar, and D. P. Singh, “Effect of ramucirumab on progression free survival and quality of life in conventional drug resistant or metastatic non-squamous variant of non-small cell lung cancers: a pilot study”, Int Surg J, vol. 12, no. 2, pp. 191–197, Jan. 2025.